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In the epidermis the autoantigen BP230 is a component of 
the hemidesmosomal plaque. We have developed a proce-
dure for the isolation of BP230 from bovine tongue mucosa 
using chromatographic means. The identity of the isolated 
protein was confirmed by its recognition by bullous pemphi-
goid autoantibodies. A mononclonal antibody (MoAb230), 
generated against the purified protein, localizes to the region 
of the plaque of the hemidesmosome with which keratin 
bundles interact. Furthermore, the tissue distribution of 
BP230, assessed using MoAb230, suggests that BP230 or an 
immunologically related protein is a component of all hemi-
desmosomes. Ultrastructural analyses of the BP230 prepara-
T he larger of the two prominent bullous pemphigoid (BP) antigens present in the basal cells of stratified squamous epithelia is a 230-kD polypeptide (BP230) (reviewed in [1 D. This protein resides in the plaque of the hemidesmosome, at the site where keratin inter-
mediate filaments appear to interact with elements of the plaque 
[2,3]. cDNAs encoding human BP230 polypeptide have been iso-
lated and sequenced [4-6]. Analyses of these sequences have raised 
many interesting questions about the possible functions, or protein-
protein interactions, of BP230 in the hemidesmosome [7]. For ex-
ample, BP230 belongs to a family of molecules that includes a 
desmosomal plaque component termed desmoplakin and an inter-
mediate filament-associated protein (or IFAP) called plectin [7 -9]. 
Several workers have speculated that desmoplakin, like plectin, 
functions as an IFAP and may be involved in the linkage of the 
intermediate filament network to the plaque of the desmosome 
[7 - 9]. The similarity in sequence between BP230, desmoplakin 
and plectin, particularly in their carboxy termini, have led the same 
workers to hypothesize that BP230 may anchor the intermediate 
filament network of the cytoskeleton to the hemidesmosomal 
plaque [7 - 9]. However, this and other potential functions ofBP230 
remain speculative and require rigorous biochemical assessment. To 
date, this has been problematic because it has proved difficult to 
purify BP230 [10]. 
In a previous publication we used bovine tongue mucosa as a 
source of BP antigens for the affinity purification of autoantibodies 
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tion reveal that the BP230 molecules assemble into macro-
molecular aggregates. The few images of individual intact 
molecules that we have observed in platinum replicas of ro-
tary shadowed BP230 preparations suggest that BP230 is an 
elongate rod-shaped molecule. This is consistent with pre-
dictions based on the primary sequence of BP230 deduced 
from BP230 cDNAs reported by others. We discuss our re-
sults in relation to the potential function ofBP230. Isolation 
ofBP230 should now allow more rigorous biochemical anal-
yses of potential protein-protein interactions ofBP230 in the 
hemidesmosome. Key words: epidermal a utoantigen/hemidesmo-
some. ] Invest Dermatoll 02:39 - 44, 1994 
from BP sera [2]. In this study, using similar starting material, we 
detail the purification of bovine BP230, the preparation of a mono-
clonal antibody against the purified polypeptide and structural anal-
yses of the isolated BP230 molecules. The purification of BP230 
should now facilitate biochemical studies on the function ofBP230 
in the hemidesmosome. 
MATERIALS AND METHODS 
Chromatography Column chromatography was carried out in Rainin 
Econocolumns (Woburn, MA). DE52 ion exchange and Sephacryl S-400 
gel Hftration media were obtained from Whatman (Maidstone, Kent, En-
gland) and Sigma Chemical Co. (St. Louis , MO) respectively. All chromato-
graphic procedures were ca.rried out in the presence of 9.5 M urea at room 
temperature by standard procedures [11]. 
Monoclonal Antibody Production Each of six Balb C mice were im-
munized with approximately 5 J.lg ofBP230. At 3- and 4-week intervals the 
mice were boosted with a further 5 J.lg of protein and blood was collected and 
tested by immunoblotting. The spleen of the mouse with the most promi-
nent polyclonal response to BP230 was removed and the spleen cells were 
fused with Sp2 myeloma cells according to standard procedures [12]. Hybri-
doma cells producing BP230 antibody were selected by immunoblotting and 
were cloned twice by limiting cell dilution [12] . 
Human Sera and Other Antibodies The BP sera, which contain auto-
antibodies against BP230. were provided by Drs. Nancy Furey and Ruth 
Freinkel of Northwestern University Medical School. The desmoplakin I 
monoclonal antibody was purchased from Boehringer-Mannheim Bio-
chemicals (Indianapolis, IN). 
Immunofluorescence and Immunogold Localization Various bo-
vine tissues were obtained from a local slaughter house and the materials 
were immediately frozen in liquid nitrogen and stored at - BO · C for later 
use. Eight- to ten-micrometer - thick sections of the frozen tissues were 
prepared in a Tissue-Tek II cryostat (Miles Laboratories, Inc., Elkhan, IN) 
and placed on slides. The sections were processed for immunofluorescence 
light and immunogold electron microscopy as deta.iled in Klatte et at [2]. 
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Immunofluorescence specimens were viewed on a Zeiss Photomicroscope 
III (Carl Zeiss , Inc., Thornwood, NY) and electron microscope sections 
were analysed as detailed below for rotary shadowing and negative stain 
electron microscopy. 
Rotary Shadowing Molecules were rotary shadowed using the glycerol 
spray technique of Tyler and Branton [1 3]. In brief, molecules in various 
glycerol containing buffers (see Results) were sprayed onto freshly cleaved 
mica using a modified airbrush (Paasche Airbrush Co., Harwodd Heights, IL 
[13]). The mica was then mounted on a rotary stage in a Balzers freeze etch 
unit (model BAF 400T, BaIzers AG, Lichtenstein), dried under vacuum, and 
then coated with a platinum/carbon film at a low angle (5°) to an approxi-
mate depth of 0.74 nm. The platinum/carbon film was then stabilized with 
carbon coated at an angle of 90° . The sample was removed from the unit and 
the replica was placed on an electron microscope grid. For negative stain, 
protein samples in urea containing buffer were placed onto carbon/formvar 
coated electron microscope grids (Ted Pella, Inc., Redding, CAl, diluted 
with 20 mM Tris-HCI buffered saline (pH7.4), rinsed with the same buffer, 
and fixed for 1 min with 1 % glutaraldehyde. The grids were rinsed exten-
sively in water, stained with 3% uranyl acetate, and then air dried. Materials 
were viewed in aJEOL 100CX electron microscope (JEOL USA, Peabody, 
MA) at an accelerating voltage of 60 kV. 
SDS-PAGE and Western Immunoblotting The epithelium of bovine 
tongue mucosa was separated from the underlying connective tissue follow-
ing treatment in 20 mM ethylenediaminetetraacetic acid (EOTA) in PBS 
contai ning 1 M KCl, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 
0.1 mg/ml tosyl arginine methyl ester (TAME) as detailed previously [2,14] . 
Preparations of both the epithelial sheet (the basal layer) and the dermis were 
made by overlaying sample buffer consisting of 8 M urea, 1 % sodium dode-
cylsulfate (SOS), 5% beta-mercaptoethanol in 65 mM Tris-HCI, pH 6.8, 
onto the " revealed" surfaces [2] . These protein samples and gel samples 
of chromatographically separated polypeptides were processed for SOS-
polyacrylamide gel electrophoresis (PAGE) on 7.5% polyacrylamide gels 
according to Laemmli (1 5). In some instances proteins were transferred from 
gels to nitrocellulose [16] . Immunoblotting on nitrocellulose was carried out 
as detailed in Zackroff et al (17). Protein concentrations determined using a 
Bio-Rad Protein Assay Kit (Bio-Rad Labs., Richmond, CAl. 
RESULTS 
Column Purification Scheme for BP230 The epithelial layer 
along with the underlying connective tissue of the mucosa of six 
cow tongues was soaked in 20 mM EDT A in PBS overnight fol-
lowed by a 5 min treatment in 1 M KCI in PBS as detailed elsewhere 
[2,14] . All of the above buffers contained the protease inhibitors 
PMSF (at 1 mM) and TAME at (O.lmg/ml). The EOTA/salttreat-
ment loosened the epithelial sheet, which was then peeled away 
from the connective tissue. Hemidesmosomes remained along the 
basal aspect of the cells in the isolated el?ithelial sheet and could be 
solubilized as detailed in Klatte et al [2J using a urea/SOS buffer. 
However, the presence of 1 % SOS in this buffer diminished the 
usefulness of the preparation for protein purification. Thus the so-
lubilization buffer was modified and a high-pH urea-containing 
buffer without SOS (9 .5 M urea, 20 mM tris-HCl, pH 8.6, 1 mM 
EOTA, 0.3% beta-mercaptoethanol, 1 % PMSF, 0.1 mg/ml TAME; 
buffer 1) was used in an attempt to solubilize hemidesmosomal 
components. Buffer 1 was overlaid on the revealed surface of the 
epithelial sheet and after 2 min was lightly scraped off. This mate-
rial was clarified by centrifugation at 100,000 X g at room tempera-
ture. The supernatant frac tion is enriched in keratin subunits and 
also contains both BP230 and BP180 as determined by Western 
immunoblotting (see below). 
To enrich for BP230 the keratin subunits were induced to poly-
merize into intermediate-sized filaments by dialyzing this fraction 
against an excess of a low-ionic-strength buffer (5 mM Tris-HCI, 
pH 7.4, 0.3% beta-mercaptoethanol, 1 mM PMSF, 0.1 mg/ml 
TAME) according to Steinert et al [18]. The polymerized filaments 
were collected by high-speed centrifugation (100,000 X g, 45 min) 
at room temperature. The gel profile of this material is shown in 
lalle s of Fig 1. Western blotting revealed that BP230 was a compo-
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Figure 1. A 6% SOS-polyacrylamide gel profile of the urea soluble fraction 
of the basal cell layers of salt split bovine tongue epithelium is shown in 
lalle s. Approximately 10 J.lg of protein were loaded onto each gel lane. The 
material shown in lalle s was subjected to ion-exchange chromatography. 
Fractions collected from the column that were enriched in high -molecular-
weight proteins as assessed by SOS-PAGE are shown in lanes 1-28. Note the 
prominent polypeptide migrating at 230 kO in lalle 13 (arrolv). Circles on 
lalle s indicate molecular-weight standards of (from top to bottom) 200, 116, 
97, and 66 kD. 
nent of the keratin-enriched pellet (see below) .* It should be noted 
that numerous additional proteins were also found in the "keratin 
pellet," including both desmoplakins I and II (Fig 1 [2]). The pres-
ence of desmoplakin I and II in our starting material reflected the 
solubilization of more than just the basal aspect of the epithelial cells 
in the salt s~lit tongue mucosa and has already been reported in 
Klatte et all2]. Pellets of BP230-containing material were either 
stored frozen at - 80°C, or were re-dissolved in buffer 1 for imme-
diate use. 
Despite a partial enrichment in BP230 in the keratin pellet de-
scribed above, there was no obvious BP230 on the comparable Coo-
massie Brilliant Blue stained gel of the preparation (lan e s, Fig 1). 
Thus a first ion exchange separation was run as a further BP230-en-
richment step. A 1.5 em X 45 cm column was packed with OE52 
ion exchange media, which had been pre-equilibrated with buffer 1. 
The keratin pellet containing BP230 was solubilized in buffer 1 and 
was then applied to the column (60 ml of buffer 1 at a concentration 
of about 30 mg/ml protein with a flow rate of 25 cm/h). The 
column was then washed with two volumes of buffer 1 at the same 
flow rate. A 480 ml 0-60-mM NaCI gradient was applied and 6-ml 
fractions were collected and analyzed by SOS-PAGE (Fig 1). Two 
proteins of 250 and 220 kO appeared as "contaminants" of several 
fractions enriched in a 230-kO polypeptide (lane 13, Fig 1). 
To further separate the 230-kO protein from other high-
molecular-weight elements including the 220- and 250-kO poly-
peptides, a second, but smaller, ion-exchange column was run under 
the same conditions. The fractions richest in the 230-kO protein 
from the first ion-exchange column (e.g., lanes 13 and 14 shown in 
Fig 1) were dialyzed against buffer 1 and adjusted to 5 mg/m!. This 
solution was then applied to a second OE52 column. The diameter 
of the small column was 1.0 cm and the total volume of the second 
column was determined by the total amount of protein present in 
this solution (15 mg protein/ml of column volume). The column 
was washed with two volumes of buffer 1 and the protein was eluted 
with an 80-ml 0-60-mM NaCllinear gradient; 1-ml fractions were 
collected and analyzed by SOS-PAGE and immunoblotting using 
BP autoantibodies to mark those fractions containing BP230 (Fig 
2). Fractions containing the greatest levels of 230-kO protein and 
the least contaminating material of similar molecular weight were 
collected (fractions shown in lanes 7 - 9 in Fig 2). These were con-
centrated in Centricon C-100 microconcentrators with several 
washes with buffer 1 to reduce the N aCI concentration in the sam-
ple. This step also resulted in the remova l of a proportion of low -
molecular-weight components, including residual keratin polypep-
tides, because of the 100-kO cut-off size of the microconcentrator. 
• Labib RS, Mutasim OF, Patel HP, Anhalt Gj, Oiaz LA: Partial purifica-
tion and characterization of the major bullous pemphigoid antigens as inter-
mediate filament associated proteins. Clill Res 33:65, 1985. 
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Figure 2. Fractions, such as that shown in latle 13 of Fig 1, were subjected to 
a second round of ion-exchange chromatography. The 6% SDS-
polyacrylamide gel profiles of samples derived from the latter are shown in 
latles 1-14. Approximately 10 flg of protein were loaded per lane. Compa-
rable samples were also transferred to nitrocellulose and blotted with a BP 
serum sample (lanes l' through 14'). Note that the fractions in latles 7-10 
are enriched in a 230-kD polypeptide that is recognized by the human 
autoantibodies (latles 7' -1 0') (arrow). The latter f~actions contain reduced 
quantities of other 111gh-molecular~welght sp~cles (compared with the 
fraction shown mlMle 1 as well as fractions shown mlatles 13 and 14 of Fig 1). 
Circles on lalle 1 show from top to bottom 200-, 116-, 97-, and 66-kD 
standards. 
As a third and final purification step the protein mixture enriched 
in 230-kD polypeptide was subjected to gel-fi ltration chromatogra-
phy on Sephac.ryl S-400. The volume. of the BP230-containing 
solution was adjusted to 0.5 ml and applted to a 1.0 X 40 cm Sepha-
cryl S-400 column. Fractions of 0.5 ml were collected and analyzed 
by SDS-PAGE (Fig 3). This purification scheme resulted in a frac-
tion that displayed a single protein band of 230 kD by SDS-PAGE 
(fractions shown in lalles 7-9, Fig 3). Figure 4 shows a flow dia-
gram of the isolation scheme that we have devised. 
Antibody Analysis of Isolated Protein and Production of a 
Monoclonal BP230 Antibody Western blotting revealed that 
the purified 230-kD po!ypeptide was recognized by BP autoant!-
bodies (fa"es A and E, Fig 3). We also generated monoclonal anti-
bodies against the fraction shown in lane 8 in Fig 3. Mice were 
immunized with slices from an SDS-PAGE gel that contained puri-
fied BP230. Serum from mice was tested periodically by immuno-
fluorescence and Western blotting. The spleen from a mouse pro-
ducing polyclonal anti-230-kD antibodies was fused with Sp2 
myeloma cells. BP230 MoAb-producing clones were selected by 
Western blotting (Fig 5). On the basis of this, one IgG monoclonal 
antibody was selected for further analyses. This antibody 
(MoAb230) recognized a 230-kD polypeptide in a basal epithelial 
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Figure 3. Fractions, such as those shown in latles 7-10 in Fig 2, were 
subjected to gel filtration. Fractions were collected and analyzed by SDS-
PAGE on 7.5% gels. Latle //I shows molecular-weight standards (the promi-
nent polypeptides from top to bottom are 200, 97, 116, 66, and 45 kD). 
Fractions 7 through 10 contain a 230-kD polypeptide (arrow). The fraction 
shown in/aIle 8 was processed for immunoblotting using a BP serum sample. 
The amido black stain of the protein profile of the fraction is shown inlalle A. 
The 230-kD polypeptide shown in lalle A is recognized by BP autoanti-
bodies (arrow, lalle B). Molecular-weight standards on lall e A are, from top to 
bottom, 200, 116,97, and 66 kD. 
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Salt split epithelium , 
Solubilize basal cells in urea 
t 
Dialyze and induce IF assembly , 
Collect I F and resolubilize in urea , 
Ion exchange I , 
Ion exchange II , 
Gel filtration 
Figure 4. A flow chart for the BP230-purification scheme. The procedures 
indicated are detailed in the text. IF, keratin intermediate filaments. 
cell extract of salt split bovine tongue mucosa but failed to react with 
any polypeptide in an extract of the connective tissue remnant of the 
same material (Fig 5) . In controls, the same 230-kD polypeptide 
was recognized by autoantibodies in various BP serum samples (the 
immunoblotting reactivity of one only is shown in Fig 5). The 
particular BP serum sample used for immunoblotting in Fig 5 con-
tained autoantibodies that recognized primarily BP230 in the epi-
thelial cell preparation but also showed strong reactivity with con-
nective tissue elements. The nature of these elements is unclear. 
MoAb230 was localized in bovine tongue mucosa and skin by 
immunogold electron microscopy. Gold particles were found asso-
ciated with the plaque of the hemidesmosome (result not shown) in 
the same location that has been reported for BP autoantibodies in 
whole human sera, affinity-purified BP230 autoantibodies, anti-
bodies raised against BP230 fusion proteins or peptides, antibodies 
raised against a 230-kD polypeptide of corneal hemidesl110somes 
and human monoclonal BP230 autoantibodies [2,3,19-21]. We 
have also analyzed a number of bovine tissues for MoAb230 reactiv-
ity by immunofluorescence. In bovine skin, tongue, bladder, and 
trachea MoAb230 stained the interface of the epithelium and the 
connective tissue, the site of hemidesmosomes [22] (Fig 6) . 
MoAb230 failed to stain gall bladder epithelium and intestine (re-
sults not shown). 
Ultrastructural Analyses of BP230 Fractions comparable to 
those shown in lanes 7 - 9 of Fig 4 were dialyzed against a variety of 
buffers (including 0.2 M acetic acid, 0 .2 M ammonium acetate, and 
5 mM triethanolamine). All of these buffers were supplemented 
with 1 ruM dithiothreitol, 1 mM PMSF, and 0.1 mg/ml TAME. In 
some instances NaCI was added to the buffer to a final concentration 
of either 25 or 50 ruM. Molecules in the resulting solutions were 
rotary shadowed using a standard glycerol spray technique at a pro-
tein concentration of about 6 Jlg/ ml [13]. Because desmoplakin I is 
of comparable molecular weight and is related to BP230, it was 
prepared as a control. A 2S0-kD polypeptide was purified from the 
same starting material as BP230. Fractions derived from the second 
ion-exchange columns that were enriched in the 250-kD protein 
were processed for gel filtration as detailed above for the isolation of 
BP230 (for example, the fraction shown in la'le 1 in Fig 2). The 
250-kD polypeptide was isolated and its identity established by 
Western blotting using a desmoplakin monoclonal antibody (Fig 
7) . The majority of the desmoplakin I molecules in our prepara-
tions, regardless of the buffer conditions, appeared as dumbbell 
shaped with prominent globular ends in rotary-shadowed images 
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Figure 5. Bovine tongue epithelium was salt split from the underlying 
connective tissue [2,14] . Extracts of both the revealed surfaces of the connec-
tive tissue (/alles A, C, and E) and the epithelium (Imres B, D, and F) were 
processed for SDS-PAGE on 7.5% gels at 20 /lg per lane and the proteins 
were then transferred to nitrocellulose. Lalles A and B show amido black 
stains of the transferred proteins (circles, from top to bottom, 200, 116, 97, 
66, and 45 kD). Lalles C and D show the immunoblotting reactivity of 
MoAb230; talles E and F show the reactivity of the autoantibodies in a BP 
serum sample. Notc ·that MoAb230 recognizes a 230-kD polypeptide only 
in lalle D. This polypeptide is also recognized by BP230 autoantibodies 
(arrow, lalle F). The BP serum sample also contains autoantibodies against 
connective tissue clements (Ialle E). 
(Fig 8). This is consistent with images of desmoplakin seen by 
others [23]. 
Compared with desmoplakin I, far fewer BP230 molecules were 
seen by rotary shadowing under the same conditions and at the same 
protein concentration (Fig 8). Moreover, much of the BP230 mate-
rial appeared to be aggregated as determined by negative stain elec-
tron microscopy (result not shown) . Two examples of the largest 
"individual" BP230 structures that we have seen are shown in A 
and B of Fig 8. Both species possessed a central "rod" domain of 
more than 140 nm in length. The central rod region of these rwo 
molecules separated rwo apparently "forked" end domains. In C-E 
of Fig 8 several other small Y -shaped structures in the BP230 prepa-
ration are presented . These were by far the most common of the 
species observed. 
DISCUSSION 
In this study we have detailed a technique for the purification of the 
hemidesmosomal protein BP230. We have also described a new 
monoclonal antibody (MoAb230) against the isolated BP230 pro-
tein. In an immunocytochemical survey of tissues using MoAb230 
we have shown that the distribution of BP230 or an immunologi-
cally related species appears limited to those tissues such as stratified 
squamous, transitional, and pseudostratified epithelia, that possess 
hemidesmosomes as defined by ultrastructural criteria. Further-
more, BP230 showed the same tissue localization pattern that has 
been reported for BP180, the second major BP autoantigen ([24], 
unpublished observations) . Indeed, antibodies against both BP230 
and BP180 stain the same tissues as the autoantibodies in whole BP 
serum as detailed by Jordan et al [25] with only one exception. The 
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Figure 6. Cryosections of bovine skin (A), tongue (B), trachea (C), and 
bladder (D) were processed for indirect immunofluorescence using 
MoAb230. A and B are at the same magnification. C and D are at slightly 
higher power. Note that MoAb230 generates staining along the epithelial 
cell-connective tissue border in all these tissue types. T he broad region of 
staining in A and D results from a somewhat tangential slice through the 
basal lamina. E, epithelium. Bar for A,B, 30 )lID. Bar for C,D, 20 )lm. 
latter workers reported tbat BP autoantibodies recognize gall blad-
der cells [25], whereas our BP230 antibody does not. However, it 
should be noted that gall bladder epithelial cells are of the simple 
columnar type and do not possess hemidesmosomes [22] . Thus the 
staining in gall bladder observed by Jordon et al [25] may reflect the 
complexity ofBP autosera, i.e., elements in tbe gall bladder may be 
recognized by non-hemidesmosomal BP autoantibodies. 
In a previous study Thacher and his colleagues attempted to pu-
rify BP230 from human cultured keratinocytes [10]. They had only 
partial success. It is certainly the case that the majority of keratino-
cytes grown ill vitro in monolayer culture express BP230 and there-
fore may be intuitively a better source of BP230 than the salt-split 
epithelial sheet of cow tongue that we use. However, the ill vitro 
culture of human epidermal cells is costly. An alternative source of 
BP230 would appear to be a preparation of bovine corneal hemides-
mosomes [20]' Unfortunately, we have been singularly unsuccessful 
Figure 7. Fractions such as those shown in 
lalle 1 of Fig 2 were processed for gel-filtra-
tion chromatography. One resulting frac-
tion that contained a single 250-kD poly-
peptide was processed for SDS-PAGE and 
then the protein was transferred to nitrocel-
lulose. Latle A is the amido black stain 
of transferred protein (circles, molecular-
weight standards, which are, from top to 
bottom, 200, 116,97, and 66 kD). Latle B 
shows the immunoreactivity of a desmopla-
kin 1 monoclonal antibody with this poly-
peptide (arrow). 
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in isolating corneal hemidesmosomes using the procedure detailed 
in Owaribe et al [20}. Thus we turned to salt-split bovine tongue 
epithelium as the source of BP230 because we had already used this 
material for the affinity purification of both BP230 and BP180 
autoantibodies [2}. In the scheme detailed here we avoid solubiliza-
tion of the entire epithelial sheet and attempt only to remove the 
most basal cell layers in the first steps of our technique. We make use 
of the fact that the BP230 and keratin of basal cells can be solubi-
lized in urea containing so lutions and that BP230 cosediments with 
polymerized keratin intermediate filaments upon removal of urea 
by dialysis. This provides an initial enrichment for BP230 prior to 
its column purification. In this regard, it is interesting to note that 
such cosedimentation of BP230 with keratin filaments has been 
used to argue that BP230 is involved in the anchorage of keratin to 
the hemidesmosomal plaque.· Although this may be the case, we 
feel it important to point out that BP180 also cosediments with 
keratin filaments under the same conditions. Moreover, our analy-
ses ofBP230 in non - urea-containing buffers imply that BP230 self 
associates into large aggregates and we may be seeing fortuitous 
cosedimentation of similarly insoluble proteins. 
Our purification scheme is relatively simple. It involves the se-
quential running of two ion-exchange and one gel filtration col-
umns. We estimate that from six tongues we obtain approximately 
30 micrograms of BP230. In this scheme, we presume that certain 
amounts of the BP230 are lost due to proteolysis. Furthermore, 
some BP230 may be lost as a minor component of column fractions 
that we discard whereas some BP230 may also be irreversibly bound 
to the column media. We emphasize that yields ofBP230 are lower 
if, during the early stages of the procedure, we either neglect to 
include protease inhibitors in the EDTA/salt solution in which we 
soak the tongue mucosa prior to peeling off the epithelial sheet or if 
we attempt to peel off the epithelial sheet from the underlying 
connective tissue before the salt treatment has had adequate time to 
penetrate and disrupt the attachment of the basal cells to the lamin 
densa of the basement membrane zone. 
The ultrastructural analyses of BP230 imply that the isolated 
molecules probably form large macromolecular aggregates in non -
urea-containing buffers. Indeed, it is tempting to speculate that the 
fuzzy-appearing material of the hemidesmosomal plaque, where 
intermediate filaments appear to bind and where BP230 antibodies 
localize, represents the ill vivo equivalent of these macro-molecular 
organizations ofBP230. It shou ld be noted that the inherent abi lity 
of the BP230 to form higher-order aggregates probably explains our 
difficulty in viewing very many individual molecules by rotary 
shadowing. Nevertheless, we have observed severa l species in our 
rotary shadowed preparations whose shape and size are close to 
those predicted by Tanaka el al [5] based on their sequence of the 
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Figure 8. Rotary shadow images of 
BP230 (A -E) and desmoplakin 1 
(F,G) . Both samples were sprayed 
in the presence of 50% glycerol and 
25 mM NaCI. Bar, 100 nm. 
human 230-kD molecule. These authors have suggested that the 
protein consists of a large alpha helical coiled-coi l rod of about 
160 nm length , with globular domains at both ends . The rotary-
shadowed images of the largest BP230 species that we have ob-
served show a central rod domain of around 140 nm, somewhat 
shorter than the predictions of T anaka et til [5}. However, interest-
ingly our images reveal that the rod domain possesses several kinks; 
this would be consistent with interruptions in the alpha helix of the 
rod domain reported by Tanaka e/ til [5}. We suppose that the 
smaller Y -shaped structures in the BP230 rotary-shadowed prepa-
rations are either fragments of BP230 or may represent molecules 
that have folded upon themselves. 
As we have already mentioned, BP230 is related in its sequence to 
both desmoplakin and plectin [7 - 9}. Thus we were surprised that 
BP230 behaves quite differently from desmoplakin and plectin in 
non-urea containing buffers. Under such conditions desmoplakin 
and plectin do not appear to self aggregate in the same manner as 
BP230 [23 ,26}. Whether this in some way reflects differences in the 
function of BP230 in the hemidesmosome compared with that of 
desmoplakin in the desmosome or plectin in the supramolecular 
organization of the cytoskeleton remains to be determined . 
BP230 appears to be recognized by autoantibodies in the majority 
of BP serum samples. This has led to the suggestion that autoanti-
bodies against BP230 playa causative role in the pathogenesis of 
bullous pemphigoid [27}. To date all the BP230 antibodies so far 
characterized localize ultrastructurally to the inner portion of the 
hemidesmosomal plaque, suggesting an intracellular location for 
this protein. In addition, sequence data and some biochemical data 
[10,24} are consistent with BP230 being an entirely cytoplasmic 
protein. How antibodies to an intracellular protein could induce the 
disruption of cell-connective tissue interaction that characterizes 
bullous pemphigoid is unclear. However, it should be noted that 
there are recent reports that antibodies may be capable of penetrat-
ing living cells [28}. Studies to assess the potential entry of BP230 
autoantibodies into living keratinocytes have not been attempted to 
our knowledge. Of course, It should be remembered that autoanti-
bodies against the extracellular domains of a second BP antigen 
(BP180), rather than BP230 autoantibodies, may induce blistering 
in bullous pemphigoid (29). 
In summary, now that we can purify BP230 we shou ld at last be in 
a position to assess potential protein-protein interactions of BP230 
by performing in vitro binding studies . In addition to keratin, it 
should be remembered that BP230 may interact with the cytoplas-
mic domains of the transmembrane proteins of the hemidesmosome 
such as BP180 and the integrill heterodimer a.6P4 [24,30,31 J. We 
are currently attempting ill vitro reconstitution studies to assess these 
possibilities. 
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